Quality of Life Research

, Volume 14, Issue 2, pp 441–451 | Cite as

Changes in quality of life in chronic psychiatric patients: A comparison between EuroQol (EQ-5D) and WHOQoL

  • Gerard van de Willige
  • Durk WiersmaEmail author
  • Fokko J. Nienhuis
  • Jack A. Jenner


It has often been postulated that simple, short questionnaires are unable to reflect complex changes in well-being of individuals with chronic psychiatric disorders. To investigate these assumptions we included two recently developed instruments to measure quality of life (the WHOQoL-Bref and the EuroQoL EQ-5D) in a randomised control trial (RCT) in which two treatment conditions were compared. Aims of the study were to assess the sensitivity and validity of these quality of life (QoL)-instruments, to establish their relationship and to examine the predictors of changes in QoL. Subjective changes in QoL were measured on three assessments waves in a period of 18 months and compared to objective changes in psychopathology and social functioning in a sample of 76 chronic schizophrenic patients who participated in the RCT. Results indicated that both WHOQoL-Bref and EuroQoL EQ-5D are capable of detecting changes in QoL over time in physical and psychological well-being. The instruments partly measure the same aspects of QoL, indicated by 50% common variance on total scores. Reduction of positive psychotic symptoms appeared to be the most important factor in improving QoL. The weighted TTO-score of EuroQoL-5D, which is often used as an index in economic evaluations of health care, did however not correspond with these changes, which indicates that it is less sensitive to changes in social and psychological well-being. It’s use as the core measure in (economic) health evaluation in the field of psychiatry therefore seems less appropriate.


EuroQol (EQ-5D) Quality of life Questionnaires Schizophrenia WHOQoL 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Struttmann, T, Fabro, M, Romieu, G,  et al. 1999Quality-of-life assessment in the old using the WHOQOL 100: Differences between patients with senile dementia and patients with cancer.Int Psychogeriatr11273279Google Scholar
  2. Atkinson, M, Zibin, S, Chuang, H 1997Characterizing quality of life among patients with chronic mental illness: A critical examination of the self-report methodology.Am J Psychiatry15499105PubMedGoogle Scholar
  3. Dickerson, FB, Ringel, NB, Parente, F 1998Subjective quality of life in out patients with schizophrenia: Clinical and utilization correlates.Acta Psychiatr Scand98124127Google Scholar
  4. Kasckow, JW, Twamley, E, Mulchahey, JJ,  et al. 2001Health related quality of well being in chronically hospitalized patients with schizophrenia: Comparison with matched outpatients.Psychiatr Res1036978Google Scholar
  5. Priebe, S, Roeder-Wanner, UU, Kaiser, W 2000Quality of life in first-admitted schizophrenia patients: A follow-up study.Psychol Med30225230CrossRefPubMedGoogle Scholar
  6. Huppert, JD, Weiss, KA, Lim, R, Pratt, S, Smith, TE 2001Quality of life in schizophrenia: Contributions of anxiety and depression.Schizophr Res51171180CrossRefPubMedGoogle Scholar
  7. Bow-Thomas, CC, Velligan, DI, Miller, AL, Olsen, J 1999Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization.Psychiatry Res86131142Google Scholar
  8. Ritsner, M 2003Predicting changes in domain-specific quality of life of schizophrenia patients.J Nerv Ment Dis191287294Google Scholar
  9. WHOQoL group. Development of the World Health Organization WHOQoL BREF Quality of Life scale. Psychol Med 1998; 28: 551–558. Google Scholar
  10. EuroQoL group. EuroQoL – a new facility for the measurement of health related quality of life. Health Policy 1990; 16: 199–208. Google Scholar
  11. Jenner, JA, Nienhuis, FJ, Wiersma, D, Van de Willige, G 2004Hallucination focused Integrative Treatment improves burden, control, and symptoms in schizophrenia patients with drug-resistant hallucinations, a RCT.Schizophr Bull30127139Google Scholar
  12. Wiersma, D, Jenner, JA, Nienhuis, FJ, Van de Willige, G 2004Hallucination focused integrative treatment improves quality of life in schizophrenia patients.Acta Psychiatr Scand109194201Google Scholar
  13. Stant, AD, TenVergert, EM, Groen, H,  et al. 2003Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations.Acta Psychiatr Scand107361368Google Scholar
  14. Jenner, JA 2002HIT: An integrative treatment for patients with persistent auditory hallucinations.Psychiatr Serv53897898Google Scholar
  15. Altman, DG 1995Practical Statistics for Medical Research.Chapman &HallLondonGoogle Scholar
  16. World Health Organization. WHO SCAN: Schedules for Clinical Assessment in Neuropsychiatry. Geneve, 1992. Google Scholar
  17. O’, Carroll RE, Smith, K, Couston, M, Cossar, JA, Hayes, PC 2000A comparison of the WHOQOL-100 and the WHOQOL-BREF in detecting change in quality of life following liver transplantation.Qual Life Res9121124Google Scholar
  18. Brooks, R 1996EuroQoL: The current state of play.Health Policy375372CrossRefPubMedGoogle Scholar
  19. Kind, P, Dolan, P, Gudex, C, Williams, A 1998Variations in population health status: Results from a United Kingdom national questionnaire survey.Br Med J316736741Google Scholar
  20. Dolan, P, Gudex, C, Kind, P, Williams, A 1996The time trade-off method: Results from a general population study.Health Econ5141154Google Scholar
  21. Kay SR, Opler LA, Lindenmayer JP. The Positive and Negative Syndrome Scale (PANSS): Rationale and standardisation. Br J Psychiatry Suppl 1989; 59–67.Google Scholar
  22. Lindenmayer, JP, Grochowski, S, Hyman, RB 1995Five factor model of schizophrenia: Replication across samples.Schizophr Res14229234Google Scholar
  23. Haddock, G, McCarron, J, Tarrier, N, Faragher, EB 1999Scales to measure dimensions of hallucinations and delusions: The psychotic symptom rating scale (PSYRATS).Psychol Med29879889Google Scholar
  24. Wiersma, D, Jong, Ad, Kraaijkamp, HJM, Ormel, J 1990GSDS-II: The Groningen Social Disabilities Schedule, Second Version.Department of Psychiatry, University of GroningenThe NetherlandsGoogle Scholar
  25. Patterson, TL, Kaplan, RM, Jeste, DV 1999Measuring the effect of treatment on quality of life in patients with schizophrenia: Focus on utility-based measures.CNS Drugs124964Google Scholar
  26. Doyle, M, Flanagan, S, Browne, S, Clarke, M, Lydon, D, Larkin, E 1999Subjective and external assessments of quality of life in schizophrenia: Relationship to insight.Acta Psychiatr Scand99466472Google Scholar
  27. Burstrom, K, Johannesson, M, Diderichsen, F 2001Health- related quality of life by disease and socio-economic group in the general population in Sweden.Health Policy555169Google Scholar
  28. Hawthorne, G, Richardson, J, Day, N, McNeil, H 2000Validation of the WHOQoL-BREF.Centre for Health Program EvaluationMelbourneGoogle Scholar
  29. Badia, XCasado, ASacristan, JAGomez, JCGregor, KJGavart, S eds. 2000the EFESO Study Group. Antipsychotic Treatment and Changes in Health Related Quality of Life in Schizophrenic Patients using the EQ-5D. DavosThe 10th Biennial Winter Workshop on SchizophreniaSwitzerlandGoogle Scholar
  30. Huppert, JD, Smith, TE 2001Longitudinal analysis of subjective quality of life in schizophrenia: Anxiety as the best symptom predictor.J Nerv Ment Dis189669675Google Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Gerard van de Willige
    • 1
  • Durk Wiersma
    • 1
    Email author
  • Fokko J. Nienhuis
    • 1
  • Jack A. Jenner
    • 1
  1. 1.Department of PsychiatryUniversity of GroningenGroningenthe Netherlands

Personalised recommendations